Your browser doesn't support javascript.
loading
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications.
Sohn, William; Resnick, Matthew J; Greenfield, Sheldon; Kaplan, Sherrie H; Phillips, Sharon; Koyama, Tatsuki; Goodman, Michael; Hamilton, Ann S; Hashibe, Mia; Hoffman, Karen E; Paddock, Lisa E; Stroup, Antoinette M; Wu, Xiao-Cheng; Penson, David F; Barocas, Daniel A.
Afiliação
  • Sohn W; *Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN †Center for Health Policy Research ‡Department of Medicine §Health Policy Research Institute, University of California, Irvine, CA ∥Department of Biostatistics, Vanderbilt University, Nashville, TN ¶Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA #Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA **Departmen
Med Care ; 54(8): 738-44, 2016 08.
Article em En | MEDLINE | ID: mdl-27219634
BACKGROUND AND OBJECTIVE: Quality measures used in pay-for-performance systems are intended to address specific quality goals, such as safety, efficiency, effectiveness, timeliness, equity, and patient-centeredness. Given the small number of narrowly focused measures in prostate cancer care, we sought to determine whether adherence to any of the available payer-driven quality measures influences patient-centered outcomes, including health-related quality of life (HRQOL), patient satisfaction, and treatment-related complications. METHODS: The Comparative Effectiveness Analysis of Surgery and Radiation study is a population-based, prospective cohort study that enrolled 3708 men with clinically localized prostate cancer during 2011 and 2012, of whom 2601 completed the 1-year survey and underwent complete chart abstraction. Compliance with 6 quality indicators endorsed by national consortia was assessed. Multivariable regression was used to determine the relationship between indicator compliance and Expanded Prostate Cancer Index Composite (EPIC-26) instrument summary scores, satisfaction scale scores (service satisfaction scale for cancer care), and treatment-related complications. RESULTS: Overall rates of compliance with these quality measures ranged between 64% and 88%. Three of the 6 measures were weakly associated with 1-year sexual function and bowel function scores (ß=-4.6, 1.69, and 2.93, respectively; P≤0.05), whereas the remaining measures had no significant relationship with patient-reported HRQOL outcomes. Satisfaction scores and treatment-related complications were not associated with quality measure compliance. CONCLUSIONS: Compliance with available nationally endorsed quality indicators, which were designed to incentivize effective and efficient care, was not associated with clinically important changes in patient-centered outcomes (HRQOL, satisfaction, or complications) within 1-year.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Qualidade de Vida / Satisfação do Paciente Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Med Care Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Qualidade de Vida / Satisfação do Paciente Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Med Care Ano de publicação: 2016 Tipo de documento: Article